Notice to Stakeholders – Clarification of Requirements Under the Food and Drug Regulations When Conducting Clinical Research With Cannabis

Health Canada is issuing this notice to clinical trial sponsors to clarify key obligations under the Food and Drug Regulations (FDR) for various types of cannabis-based clinical research.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis aux intervenants – Clarification des exigences prévues par le Règlement sur les aliments et drogues lors de la conduite de recherches cliniques sur le cannabis
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-02-05 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["avis aux intervenants", "clarification des exigences", "Règlement sur les aliments et drogues", "essai clinique", "recherche clinique", "cannabis"], "en": ["notice to stakeholders", "clarification of requirements", "Food and Drug Regulations", "clinical trial", "clinical research", "cannabis"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source